Quick Summary

Turkey Tail (Trametes versicolor) is a medicinal mushroom studied for its immunomodulatory and potential supportive roles in cancer care. Polysaccharide-K (PSK) and related extracts have been used adjunctively with chemotherapy for colorectal and breast cancers. Preclinical and some clinical data suggest immunomodulatory, anti-tumor, and supportive benefits, but evidence certainty is often low or very low. Safety data indicate a generally favorable profile with mild side effects. Evidence on drug interactions and cautions in pregnancy or breastfeeding is limited and requires further study.

What is it

Turkey Tail is a common polypore mushroom native to numerous regions worldwide. Its scientific name is Trametes versicolor. It is recognized by its multicolored, banded appearance reminiscent of a turkey’s tail. Traditionally used in Eastern medicine, Turkey Tail has gained attention for its bioactive compounds, particularly polysaccharides, which are extracted for use as dietary supplements and adjuncts in integrative cancer care.

Traditional Uses

  • Support immune health
  • Adjunctive use in cancer treatments to potentially enhance immune response
  • General health tonic in traditional Chinese and Japanese medicine

Active Compounds

Key active constituents primarily include polysaccharides such as Polysaccharide-K (PSK) and Polysaccharopeptide (PSP). These compounds are believed to mediate immunomodulatory effects through interactions with the gut-associated lymphoid tissue and systemic immune cells. Other bioactive molecules potentially contribute to anti-inflammatory and antioxidant activities.

Potential Benefits with Evidence Levels

Cancer Supportive Care

Description: Adjunctive use of Trametes versicolor extracts (e.g., PSK) with chemotherapy may improve survival in colorectal cancer and support immune function during cancer treatment.

Evidence Level: Low to very low certainty evidence from randomized controlled trials involving human subjects.

  • A Cochrane systematic review including seven RCTs reported low-certainty evidence suggesting a small improvement in 5-year survival in colorectal cancer patients receiving PSK alongside chemotherapy, though effects on treatment adverse events remain uncertain.
    (PMID: 36445793)
  • A scoping review suggested medicinal mushrooms including Turkey Tail may reduce chemotherapy side effects and support immune function in gastric, breast, and colorectal cancers, but highlighted the need for larger controlled trials.
    (PMID: 37193480)
  • A review of anticancer potential in breast cancer showed promising preclinical and early clinical immunomodulatory effects; however, clinical evidence is limited.
    (PMID: 41150756)

Immunomodulation

Description: Polysaccharides from Turkey Tail have shown immunomodulatory effects including enhancement of antitumor immunity.

Evidence Level: Primarily preclinical with some early-phase clinical data supporting immunological benefits; clinical translation is ongoing.

  • Reviews describe immunostimulatory effects mainly via modulation of gut-associated immune cells and systemic antitumor immune responses.
    (PMID: 41683739)
  • Antitumor activity of edible mushrooms including Turkey Tail highlights immunomodulatory polysaccharides as key bioactive components.
    (PMID: 40507156)

Anti-inflammatory and Antioxidant Properties

Description: Polysaccharides and other compounds from Turkey Tail possess anti-inflammatory and antioxidant activities demonstrated in preclinical studies.

Evidence Level: Primarily preclinical with potential clinical relevance.

  • Systematic evaluation suggests anti-inflammatory properties possibly mediated via key signaling pathways in immune regulation.
    (PMID: 41445832)

Side Effects

Turkey Tail extracts, particularly polysaccharide-K, are generally well tolerated with a favorable safety profile in clinical use. Mild side effects may occur, but serious adverse events are not well documented. Evidence from clinical trials is uncertain regarding impacts on adverse effects related to chemotherapy, with no consistent reports of severe adverse reactions.

Drug Interactions

There is limited direct clinical evidence regarding drug interactions. Some reviews caution potential interactions mediated via cytochrome P450 enzymes and drug transporters, especially when combined with anticancer drugs. Further research is warranted to better characterize potential herb-drug interactions involving Turkey Tail.

Who Should Avoid It

  • Individuals who are pregnant or breastfeeding should avoid use or consult healthcare providers due to insufficient safety evidence.
  • People with known mushroom allergies or sensitivities may wish to avoid Turkey Tail supplements.
  • Caution is advised in specific populations lacking robust safety data.

Evidence Limitations

  • Most clinical evidence is of low or very low certainty with small sample sizes.
  • There is heterogeneity in extract preparations, dosages, and study designs across trials.
  • Limited data are available on long-term safety and standardized treatment protocols.
  • Lack of large, well-designed randomized controlled trials especially for clinical outcomes beyond survival.
  • Insufficient data on herb-drug interactions, pregnancy, and breastfeeding safety.

References

  • PMID: 36445793 — Cochrane systematic review on Coriolus versicolor in colorectal cancer showing low-certainty survival benefit and uncertain effects on adverse events.
  • PMID: 37193480 — Scoping review of medicinal mushrooms including Turkey Tail for treatment support in gastric, breast, and colorectal cancers.
  • PMID: 41150756 — Review focused on anticancer effects and clinical evidence in breast cancer.
  • PMID: 41683739 — Review detailing immunomodulatory effects of medicinal mushrooms including Turkey Tail.
  • PMID: 40507156 — Recent review on anti-tumor activities of edible mushrooms including Turkey Tail.
  • PMID: 41226533 — Review on herb-drug interactions in cancer care highlighting the need for more research on mushroom compounds.
  • PMID: 31567464 — Discussion on safety and herb-drug interaction concerns of commonly used herbal supplements in oncology including Turkey Tail.
  • PMID: 35910346 — Review on safety profile and therapeutic applications of medicinal mushrooms including Turkey Tail.

Last Reviewed

June 2024

Disclaimer: This information is provided for educational purposes only and is not intended as medical advice. Turkey Tail supplements should not replace conventional medical treatments. Consult a healthcare professional before starting any new supplement, especially if you are pregnant, breastfeeding, have existing health conditions, or are taking medications.